Gefitinib treatment

2 trials

Sponsors

Central Japan Lung Study Group

Conditions

Adenocarcinoma of the lungNon-Small-Cell Lung Cancer

Phase 2

A Phase II study of Gefitinib as First-Line Treatment for Elderly Patients with Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations.

Active, not recruitingJPRN-UMIN000001863

Central Japan Lung Study GroupNon-Small-Cell Lung Cancer

Start: 2009-04-01Target: 19Updated: 2026-06-29

A Phase II Study of Gefitinib Monotherapy as First-Line Treatment for Elderly Patients with Stage IIIB /IV Adenocarcinoma of the Lung

Active, not recruitingJPRN-UMIN000006144

Central Japan Lung Study GroupAdenocarcinoma of the lung

Start: 2005-02-01Target: 32Updated: 2026-06-29